Utah medical cannabis sales reached a record $17.4 million in July, bringing the state’s total for the first seven months of 2026 to approximately $117.8 million, according to the newest monthly report from the Utah Department of Health and Human Services.
The July total, $17,413,900, was based on product-category sales listed in the report. The figure includes $8,616,600 in cartridges and pens, $5,621,600 in flower, $2,908,400 in infused edibles, $117,600 in infused non-edible products and $149,700 in non-medicated products.
The total was the highest monthly sales figure recorded since Utah’s medical cannabis program began sales in 2020.
Sales increased by $971,100, or about 5.9%, from the $16,442,800 reported in June.
The new year-to-date total was calculated by adding July’s sales to the $100.4 million in medical cannabis sales recorded during the first half of the year.
The report shows Utah now has 116,177 patients with active medical cannabis cards. That is an increase of 705 from the 115,472 active patients listed in the previous report, continuing the program’s steady growth. The state also had 1,035 registered recommending medical providers, 152 paper-only recommending providers, 965 pharmacy agents, 950 processor or cultivator agents and 445 courier agents.
Among active patients, the largest age group was 31 to 40, with 30,405 patients, followed by those ages 41 to 50 at 25,893 and those ages 21 to 30 at 25,407. Patients 65 and older accounted for 12,969 cardholders.
Persistent pain remained by far the most common qualifying condition, with 101,738 patients listed under that category. PTSD was second at 5,457 patients, followed by nausea at 2,497 and cancer at 2,096.
The report also shows 64,759 patients made at least one purchase during the previous 30 days, while 37,783 made two or more purchases and 23,390 made at least three. Over the previous 90 days, 88,763 patients made at least one purchase.
Utah legalized medical cannabis in 2018, with the state’s first medical cannabis pharmacy opening in March 2020. The program does not allow recreational marijuana sales.
